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INTRODUCTION
Opitz syndrome (OS; MIM 145410 and 300000) is also
known as hypertelorism-hypospadias syndrome, and it is a
congenital midline malformation syndrome that was formerly
reported as two separate entities, G and BBB syndromes (1,
2). The constellation of clinical manifestations that define
OS include: 1) congenital heart defects such as atrial and ven-
tricular septal defects, patent ductus arteriosus and coarcta-
tion of the aorta; 2) a characteristic facial appearance (a broad
nasal bridge, hypertelorism and low-set posteriorly rotated
ears) with labiopalatine and laryngotracheal abnormalities;
3) dysphagia and gastro-oesophageal reflux; 4) abnormalities
of the central nervous system (including major motor skill
defects and delayed development); and 5) genital anomalies,
e.g. hypospadias (3).
OS is genetically heterogeneous because it has both an X-
linked (Xp22.3) and an autosomal (22q11.2) loci (4). The
gene responsible for X-linked OS (XLOS) is the MID1 gene
which encodes a microtubule-associated RING-Bbox-Coiled-
coil (RBCC) protein (5). Mutations in the MID1 gene have
been found either in familial or sporadic cases, and indicat-
ed as the cause of the X-linked form of OS (XLOS). To date,
about 35 distinct MID1 mutations including missense, non-
sense, and splicing mutations, small insertions, small dele-
tions and complex rearrangements have been identified and
most of those are concentrated in the 3′ end of the gene (5-7).
We recently found a four-year male patient with multiple
midline defects and we identified a novel mutation in the
MID1 gene in this patient and his mother, which enabled
us to make a successful prenatal diagnosis for two consecu-
tive fetuses.
MATERIALS AND METHODS
Patients
The male patient was born in 2002 by Cesarean section
after 40 weeks of pregnancy and he was the first live born
baby. The birth weight was approximately 3,800 g and he
was grunting immediately after delivery. He presented with
hyperterolism, a broad nasal bridge, a laryngeal cleft and hy-
pospadias. He experienced many episodes of aspiration pneu-
monia and gastroesophageal reflux. His mother has hyper-
telorism without any other dysmorphic findings (Table 1).
Fluorescent in situ hybridization (FISH)
To rule out the autosomal form of OS, FISH studies using
Hyun-Jung Cho, Mee-yong Shin*, 
Kang-Mo Ahn*
,� , Sang Il Lee*, 
Hee-Jin Kim, Chang-Seok Ki
� , 
Jong-Won Kim
Departments of Laboratory Medicine and Pediatrics*,
Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, Korea
� These two authors contributed equally to this work.
Address for correspondence
Chang-Seok Ki, M.D.
Department of Laboratory Medicine, Samsung Medical
Center, Sungkyunkwan University School of Medicine,
50 Ilwon-dong, Gangnam-gu, Seoul 135-710, Korea
Tel : +82.2-3410-2709, Fax : +82.2-3410-2719
E-mail : changski@skku.edu
*This work was supported by the Samsung Biomedical
Research Institute grant, #SBRI C-A5-102-1.
790
J Korean Med Sci 2006; 21: 790-3
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
X-linked Opitz G/BBB Syndrome: Identification of a Novel Mutation
and Prenatal Diagnosis in a Korean Family 
X-linked Opitz G/BBB syndrome (XLOS; MIM 300000) is a rare multiple congenital
anomaly disorder that is characterized by facial anomalies, laryngeal/tracheal/eso-
phageal defects and genitourinary abnormalities. XLOS is caused by mutations in
the MID1 gene which encodes a microtubule-associated RING-Bbox-Coiled-coil
(RBCC) protein. We recently found a four-year Korean male patient who was sus-
pected of having XLOS. Mutation analysis of the MID1 gene in the patient and his
mother demonstrated that the patient had a novel insertion mutation (c.1798_1799-
insC), and his mother was a heterozygous carrier of the mutation. After identifica-
tion of the causative mutation in this family, prenatal diagnosis of two consecutive
fetuses were successfully undertaken. This is the first report on a genetically con-
firmed case of XLOS in Korea.
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the TUPLE1 probe for the DiGeroge/VCFS critical region
(Vysis, Downers Grove, IL, U.S.A.) were accomplished accord-
ing to the manufacturer’s specifications with minor modifi-
cations. We analyzed 200 interphase nuclei from peripheral
blood lymphocytes of the patient.
Mutation analysis
Genomic DNA was extracted from peripheral blood leuko-
cytes with using the Wizard Genomic DNA Purification kit
(Promega, Madison, WI, U.S.A.) according to the manufac-
turer’s instructions. All the coding exons and their flanking
introns of the MID1 gene were amplified by using primer
sets that were designed by the authors (these are available
upon request). The polymerase chain reaction (PCR) was per-
formed with a thermal cycler (Model 9700, Applied Biosys-
tems, Foster City, CA, U.S.A.) as follows: 32 cycles of denat-
uration at 94℃ for 30 sec, annealing at 60℃ for 30 sec and
extension at 72℃ for 30 sec. After treating the amplicon (5
L) with 10 U shrimp alkaline phosphatase and 2 U exonu-
clease I (USB Corp., Cleveland, OH, U.S.A.), direct sequenc-
ing was performed with the BigDye Terminator Cycle Sequ-
encing Ready Reaction kit (Applied Biosystems) on an ABI
Prism 3100 genetic analyzer (Applied Biosystems). 
Prenatal diagnosis
After identifying the causative mutation in this family,
chorionic villus sampling (CVS) was performed at 74 days
of gestation in a 33-yr-old patient’s mother (gravida 2, para
1). The DNA was extracted according to standard procedures,
and exon 13 of the MID1 gene was sequenced and analyzed
on an ABI Prism 3100 genetic analyzer (Applied Biosystems).
Cytogenetic analysis was then done by GTG banding. Amnio-
centesis was carried out for the next pregnancy and the same
procedure was done for the CVS.
RESULTS
Mutation analysis
On the FISH analysis, all the cells had two red signals of
a similar intensity for TUPLE1 and two green signals of the
locus-specific identifier (LSI) ARSA. Mutation analysis of
the MID1 gene by direct sequencing of all nine coding exons
and intron/exon boundaries identified the c.1798_1799insC
mutation in exon 13 (Fig. 1). This mutation is located in the
second codon position of the amino acid histidine 600, which
produces a frameshift leading to the production of a chimeric
599-residue MID1 protein ending with 12 amino acids that
are derived from a wrong reading frame. The patient’s mother
was a carrier of the same mutation.
Prenatal diagnosis
After identifying the causative mutation in this family, the
parents of the patient requested prenatal diagnosis for the next
two consecutive fetuses. Genomic DNA was isolated from
the chorionic villi of the 2nd baby and from the amniotic
fluid of the 3rd baby, and this was subsequently screened for
the presence of the c.1798_1799insC mutation by perform-
ing sequence analysis of the MID1 exon 13. The mutant-type
allele was observed in both fetuses. According to the cyto-
Phenotype
This study
Reported frequency
of each phenotype 
(9)
Male with
MID1
mutation
Patient Mother
Female with
MID1
mutation
Hypertelorism/telecanthus Present Present 98.0% 100.0% 
(48/49) (18/18)
Broad nasal bridge Present Present 41.7% 20.0%
(15/36) (2/10)
Anteverted nares Absent Absent 37.1% 11.1%
(13/35) (1/9)
Cleft lip and/or palate Absent Absent 52.2% 30.0%
(24/46) (3/10)
High arched palate Present Absent 12.0%  10.0% 
(3/25) (1/10)
Laryngotracheoeso- Present Absent 54.2% 30.0%
phageal anomaly (26/48) (3/10)
Dysphagia/gastroeso- Present Absent 36.1% 20.0%
phageal reflux (13/36) (2/10)
Cardiac structural defects Absent Absent 26.1% 0.0%
(12/46) (0/9)
Anal atresia/anterior anus Absent Absent 26.1% 11.1%
(12/46) (1/9)
Hypospadias Present Absent 83.7% 0.0%
(41/49) (0/8)
Genitourinary defects Absent Absent 17.9% 10.0%
(5/28) (1/10)
Developmental delay Absent Absent 50.0% 10.0%
(21/42) (1/10)
Mental retardation Absent Absent 5.9%  0.0% 
(1/17) (0/8)
Brain anomaly Absent Absent 6.3% 0.0%
(2/32) (0/10)
Ear abnormality Absent Absent 51.4%  20.0%
(19/37) (2/10)
Hernia/abdominal wall  Absent Absent 5.9% 12.5%
defect (1/17) (1/8)
Cranial/suture abnormality Absent Absent 5.9% 12.5%
(1/17) (1/8)
Renal abnormality Absent Absent 5.9% 0.0%
(1/17) (0/8)
Skeletal abnormality Absent Absent 5.9% 0.0%
(1/17) (0/8)
Large fontanel Absent Absent 11.8% 0.0%
(2/17) (0/8)
Table 1. Clinical findings of the patient and his mother with the
MID1 gene mutationgenetic analysis, the 2nd baby was male and this fetus was
terminated according to parents’ demand; the 3rd baby was
female and delivered.
DISCUSSION
In the present study, we report the results of the MID1 gene
mutation analysis that was done in a male patient with XLOS
and his mother. After identification of the causative muta-
tion in this family, we successfully performed prenatal diag-
nosis for the next two fetuses. Our patient had typical phe-
notypes except for his neurologic abnormalities and congen-
ital heart defects, as compared to those previously reported
(5-9). There is considerable clinical variability in the presen-
tation of OS, even among the male patients from the same
family who share identical MID1 mutations (7), and this sug-
gests that other factors modifying the OS phenotype may
exist. As far as the genotype/phenotype correlations are con-
cerned, Pinson et al. (10) reported that vermis hypoplasia or
agenesis was the most common brain anomaly observed in OS
patients with MID1 mutations, and this has particularly been
seen in association with the R495X mutation (p<0.0001).
So et al. (9) suggested that only laryngo-tracheo-esophageal
malformations might correlate with MID1 mutation. Recent-
ly, Mnayer et al. (11) suggested that OS patients with muta-
tions in the FNIII domain of MID1 resulting retained activity
of the FNIII domain would have a milder phenotype with-
out severe brain damage.
Considering the absence of a cure and complete penetrance,
prenatal diagnosis appears to be a considerable approach to
reduce the burden of this disease on the individual family
and also on society. Prenatal diagnosis of OS, including dis-
criminating the sex, is important because the daughters of
known or suspected carriers are not likely to be functionally
impaired or have an obvious diagnosis of carriers. The finding
of hypertelorism as a pervasive sign in the carriers of XLOS,
along with a personal or family history of cleft lip, cleft palate
or other manifestations of XLOS, may be important as a pre-
natal screening tool (9). Most XLOS families carry a unique
mutation and screening of the whole MID1 gene is labori-
ous and time consuming. Therefore, prenatal direct mutation
analysis can be timely done in those families of which the
mutation is known beforehand.
In summary, we found a novel MID1 mutation in a Korean
male patient suffering from XLOS and his mother, and this
enabled us to make a successful prenatal diagnosis in this
family. To the best of our knowledge, this is the first report
on a genetically confirmed case of XLOS in Korea.
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